VHL and renal cell carcinoma: The VHL status has been reported in several studies to affect the sensitivity of ccRCC cells to various drug therapies; however, multiple lines of evidence suggest that other molecular differences may also contribute to the differential sensitivity of RCC cells to drugs [16,17,18].